Home > Intercept Pharmaceuticals Salary

Intercept Pharmaceuticals Salary

  • 32
  • 80
  • 79
Intercept Pharmaceuticals average salary is $70,048, median salary is $71,573 with a salary range from $66,664 to $71,906.
Intercept Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Intercept Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 3 Intercept Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Coastal Engineer 71,906-71,906 San Francisco, CA, 94101 2016 Intercept Pharmaceuticals Coastal Engineer Salaries (2)
Intercept Pharmaceuticals San Francisco, CA Salaries
Coastal Engineer 66,664-66,664 Seattle, WA, 98060 2016 Intercept Pharmaceuticals Coastal Engineer Salaries (2)
Intercept Pharmaceuticals Seattle, WA Salaries
Hydrologist Ii 71,573-71,573 San Francisco, CA, 94101 2015 Intercept Pharmaceuticals Hydrologist Ii Salaries (1)
Intercept Pharmaceuticals San Francisco, CA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Intercept Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Intercept Pharmaceuticals Jobs
See more Intercept Pharmaceuticals Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
987

All Patents

204

Grant Patents

638

Patents Pending

169

Patents Families

More Recent
Intercept Pharmaceutic... Information
  • Intercept Pharmaceuticals
  • Industry: BioTech/Drugs
  • City: New York, NY
  • New York City-based Intercept Pharmaceuticals, Inc. is a clinical stagebiopharmaceutical company focused on developing small molecule drugs forthe treatment of chronic liver and metabolic diseases. Since 2002,Intercept researchers have published extensively on the key role of thefarnesoid X receptor (FXR) as a regulator of bile and cholesterolmetabolism in the liver with preclinical data from numerous studiesproviding strong rationale for the advancement of FXR agonists ashepatoprotective therapeutics in chronic liver disease. The company intendsto lead in the advancement of drug candidates acting on FXR and other bileacid receptors and is developing a pipeline of novel lead compounds formultiple indications.